Dépôt numérique
RECHERCHER

Cannabis use is associated with reduced prevalence of progressive stages of alcoholic liver disease

Adejumo, Adeyinka Charles; Ajayi, Tokunbo Opeyemi; Adegbala, Oluwole Muyiwa; Adejumo, Kelechi Lauretta; Alliu, Samson; Akinjero, Akintunde Micheal; Onyeakusi, Nnaemeka Egbuna; Ojelabi, Ogooluwa; Bukong, Terence Ndonyi (2018). Cannabis use is associated with reduced prevalence of progressive stages of alcoholic liver disease Liver International , vol. 38 , nº 8. p. 1475-1486. DOI: 10.1111/liv.13696.

Ce document n'est pas hébergé sur EspaceINRS.

Résumé

BACKGROUND: Abusive alcohol use has well-established health risks including causing liver disease (ALD) characterized by alcoholic steatosis (AS), steatohepatitis (AH), fibrosis, cirrhosis (AC) and hepatocellular carcinoma (HCC). Strikingly, a significant number of individuals who abuse alcohol also use Cannabis, which has seen increased legalization globally. While cannabis has demonstrated anti-inflammatory properties, its combined use with alcohol and the development of liver disease remain unclear.

AIM: The aim of this study was to determine the effects of cannabis use on the incidence of liver disease in individuals who abuse alcohol.

METHODS: We analysed the 2014 Healthcare Cost and Utilization Project-Nationwide Inpatient Sample (NIS) discharge records of patients 18 years and older, who had a past or current history of abusive alcohol use (n = 319 514). Using the International Classification of Disease, Ninth Edition codes, we studied the four distinct phases of progressive ALD with respect to three cannabis exposure groups: non-cannabis users (90.39%), non-dependent cannabis users (8.26%) and dependent cannabis users (1.36%). We accounted for the complex survey sampling methodology and estimated the adjusted odds ratio (AOR) for developing AS, AH, AC and HCC with respect to cannabis use (SAS 9.4).

RESULTS: Our study revealed that among alcohol users, individuals who additionally use cannabis (dependent and non-dependent cannabis use) showed significantly lower odds of developing AS, AH, AC and HCC (AOR: 0.55 [0.48-0.64], 0.57 [0.53-0.61], 0.45 [0.43-0.48] and 0.62 [0.51-0.76]). Furthermore, dependent users had significantly lower odds than non-dependent users for developing liver disease.

CONCLUSIONS: Our findings suggest that cannabis use is associated with a reduced incidence of liver disease in alcoholics.

Type de document: Article
Mots-clés libres: alcohol; cannabis; drug abuse; liver disease
Centre: Centre INRS-Institut Armand Frappier
Date de dépôt: 28 févr. 2019 15:17
Dernière modification: 28 févr. 2019 15:17
URI: http://espace.inrs.ca/id/eprint/7423

Actions (Identification requise)

Modifier la notice Modifier la notice